Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$974M |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
Amazon
AMZN
|
+$768M |
| 4 |
Kenvue
KVUE
|
+$659M |
| 5 |
Blackstone
BX
|
+$597M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$413M |
| 2 |
Texas Instruments
TXN
|
+$219M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 4 |
Pfizer
PFE
|
+$192M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| 1 | Technology | 27.72% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
NovoCure
NVCR
$1.36B
| $24.3M | ﹤0.01% |
1,504,991
+44,462
| +3% | +$718K |
|
1702
Legend Biotech
LEGN
$6.11B
| $24.1M | ﹤0.01% |
361,202
+27,413
| +8% | +$1.83M |
|
1703
Liberty Live Group Series C
LLYVK
$9.23B
| $24.1M | ﹤0.01% |
+749,794
| New | +$24.1M |
|
1704
Stewart Information Services
STC
$2.09B
| $24.1M | ﹤0.01% |
549,384
+19,459
| +4% | +$852K |
|
|
LADR
1705
Ladder Capital
LADR
$1.48B
| $24M | ﹤0.01% |
2,343,381
+98,703
| +4% | +$1.01M |
|
1706
Recursion Pharmaceuticals
RXRX
$2.11B
| $24M | ﹤0.01% |
3,138,690
+329,547
| +12% | +$2.52M |
|
1707
Claros Mortgage Trust
CMTG
$529M
| $24M | ﹤0.01% |
2,165,186
+67,943
| +3% | +$753K |
|
1708
Adeia
ADEA
$1.71B
| $24M | ﹤0.01% |
2,246,210
+83,752
| +4% | +$895K |
|
1709
Zeta Global
ZETA
$4.84B
| $24M | ﹤0.01% |
2,872,030
+346,809
| +14% | +$2.9M |
|
1710
Rhythm Pharmaceuticals
RYTM
$6.39B
| $24M | ﹤0.01% |
1,045,057
+71,707
| +7% | +$1.64M |
|
1711
LeMaitre Vascular
LMAT
$2.09B
| $23.9M | ﹤0.01% |
437,927
+17,108
| +4% | +$932K |
|
1712
Zentalis Pharmaceuticals
ZNTL
$107M
| $23.8M | ﹤0.01% |
1,186,837
+119,236
| +11% | +$2.39M |
|
1713
UFP Technologies
UFPT
$1.54B
| $23.8M | ﹤0.01% |
147,305
+5,382
| +4% | +$869K |
|
1714
Seadrill
SDRL
$2.04B
| $23.8M | ﹤0.01% |
530,638
+30,483
| +6% | +$1.37M |
|
1715
Ryanair
RYAAY
$31.1B
| $23.7M | ﹤0.01% |
609,363
+374,150
| +159% | +$14.5M |
|
1716
Empire State Realty Trust
ESRT
$1.34B
| $23.7M | ﹤0.01% |
2,944,144
+94,812
| +3% | +$762K |
|
1717
Encore Capital Group
ECPG
$1.02B
| $23.7M | ﹤0.01% |
495,142
+16,284
| +3% | +$778K |
|
1718
Tencent Music
TME
$38.5B
| $23.6M | ﹤0.01% |
3,719,558
+283,422
| +8% | +$1.8M |
|
1719
Harmony Biosciences
HRMY
$1.86B
| $23.6M | ﹤0.01% |
719,376
+58,070
| +9% | +$1.9M |
|
1720
Constellium
CSTM
$2.08B
| $23.6M | ﹤0.01% |
1,294,187
+72,876
| +6% | +$1.33M |
|
1721
Krispy Kreme
DNUT
$541M
| $23.6M | ﹤0.01% |
1,888,554
+230,673
| +14% | +$2.88M |
|
1722
Hawkins
HWKN
$3.62B
| $23.5M | ﹤0.01% |
399,519
+19,986
| +5% | +$1.18M |
|
1723
Universal Corp
UVV
$1.38B
| $23.5M | ﹤0.01% |
498,003
+15,210
| +3% | +$718K |
|
|
PRMW
1724
DELISTED
Primo Water Corporation
PRMW
| $23.5M | ﹤0.01% |
1,700,303
+94,496
| +6% | +$1.3M |
|
|
PYCR
1725
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $23.3M | ﹤0.01% |
1,019,487
+168,308
| +20% | +$3.84M |
|